DK1668017T3 - Disulfid-, sulfid-, sulfoxid- og sulfonderivater af cykliske sukkerarter og anvendelser deraf - Google Patents

Disulfid-, sulfid-, sulfoxid- og sulfonderivater af cykliske sukkerarter og anvendelser deraf

Info

Publication number
DK1668017T3
DK1668017T3 DK04765682T DK04765682T DK1668017T3 DK 1668017 T3 DK1668017 T3 DK 1668017T3 DK 04765682 T DK04765682 T DK 04765682T DK 04765682 T DK04765682 T DK 04765682T DK 1668017 T3 DK1668017 T3 DK 1668017T3
Authority
DK
Denmark
Prior art keywords
disulfide
sulfoxide
sulfide
sulfone derivatives
cyclic sugars
Prior art date
Application number
DK04765682T
Other languages
Danish (da)
English (en)
Inventor
Moliner Jose Repolles
Perez-Rasilla Eduardo La Salas
Coy Francisco L Pubill
Original Assignee
Lacer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lacer Sa filed Critical Lacer Sa
Application granted granted Critical
Publication of DK1668017T3 publication Critical patent/DK1668017T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Endocrinology (AREA)
  • Neurosurgery (AREA)
  • Obesity (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Biochemistry (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Toxicology (AREA)
  • Dermatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK04765682T 2003-10-03 2004-09-29 Disulfid-, sulfid-, sulfoxid- og sulfonderivater af cykliske sukkerarter og anvendelser deraf DK1668017T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200302368A ES2258365B1 (es) 2003-10-03 2003-10-03 Derivados de disulfuro, sulfuro, sulfoxido y sulfona de azucares ciclicos y sus usos.
PCT/EP2004/010882 WO2005037842A1 (en) 2003-10-03 2004-09-29 Disulfide, sulfide, sulfoxide, and sulfone derivatives of cyclic sugars and uses thereof

Publications (1)

Publication Number Publication Date
DK1668017T3 true DK1668017T3 (da) 2009-05-11

Family

ID=34451643

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04765682T DK1668017T3 (da) 2003-10-03 2004-09-29 Disulfid-, sulfid-, sulfoxid- og sulfonderivater af cykliske sukkerarter og anvendelser deraf

Country Status (34)

Country Link
US (3) US7521571B2 (pt)
EP (1) EP1668017B1 (pt)
JP (2) JP4809769B2 (pt)
KR (1) KR101141683B1 (pt)
CN (1) CN1863805B (pt)
AP (1) AP1976A (pt)
AR (1) AR045962A1 (pt)
AT (1) ATE423781T1 (pt)
AU (1) AU2004281916B2 (pt)
BR (1) BRPI0415020A (pt)
CA (1) CA2540500C (pt)
DE (2) DE602004019666D1 (pt)
DK (1) DK1668017T3 (pt)
EA (1) EA008942B1 (pt)
EC (1) ECSP066542A (pt)
ES (2) ES2258365B1 (pt)
GB (1) GB2421241B (pt)
GE (1) GEP20084490B (pt)
GT (1) GT200400200A (pt)
HR (1) HRP20090152T3 (pt)
IL (1) IL174371A0 (pt)
IS (1) IS8436A (pt)
MX (1) MXPA06003610A (pt)
NO (1) NO20061872L (pt)
NZ (1) NZ546043A (pt)
PA (1) PA8614201A1 (pt)
PE (1) PE20050436A1 (pt)
PL (1) PL1668017T3 (pt)
PT (1) PT1668017E (pt)
RS (1) RS20060241A (pt)
SI (1) SI1668017T1 (pt)
UY (1) UY28547A1 (pt)
WO (1) WO2005037842A1 (pt)
ZA (1) ZA200603475B (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2258365B1 (es) 2003-10-03 2007-12-01 Lacer, S.A. Derivados de disulfuro, sulfuro, sulfoxido y sulfona de azucares ciclicos y sus usos.
EP1941876A1 (en) * 2006-12-28 2008-07-09 Lacer, S.A. Isosorbide mononitrate derivatives for the treatment of Inflammation and ocular hypertension
ES2332565B1 (es) * 2007-01-23 2010-10-21 Lacer, S.A. Uso de derivados de mononitrato de dianhidrohexita como agentes antiinflamatorios.
US20080193530A1 (en) * 2007-02-13 2008-08-14 Brent Blackburn Use of ranolazine for the treatment of non-coronary microvascular diseases
CA2678515A1 (en) * 2007-02-13 2008-08-21 Cv Therapeutics, Inc. Use of ranolazine for the treatment of cardiovascular diseases
US20090111826A1 (en) * 2007-02-13 2009-04-30 Louis Lange Use of ranolazine for the treatment of cardiovascular diseases
CA2678319A1 (en) * 2007-02-13 2008-08-21 Cv Therapeutics, Inc. Use of ranolazine for the treatment of coronary microvascular diseases
WO2008116083A1 (en) * 2007-03-22 2008-09-25 Cv Therapeutics, Inc. Use of ranolazine for elevated brain-type natriuretic peptide
ES2402675T3 (es) * 2007-05-31 2013-05-07 Gilead Palo Alto, Inc. Ranolazina para el péptido natriurético de tipo cerebral a niveles elevados
IE20070934A1 (en) 2007-12-21 2009-06-24 Trinity College Dublin Efficient aspirin prodrugs
US8003811B2 (en) * 2008-02-07 2011-08-23 Nicox S.A. Nitric oxide donor compounds
EP2149576A1 (en) * 2008-07-22 2010-02-03 Lacer, S.A. Isosorbide Nitrates having vasodilating activity
EP2149577B1 (en) * 2008-07-22 2011-04-27 Lacer, S.A. New stereospecific method for the preparation of dioxa-bicyclooctane compounds
EP2177216A1 (en) * 2008-10-13 2010-04-21 Lacer, S.A. Use of dianhydrohexite mononitrate derivatives as healing agents
WO2010055138A1 (en) * 2008-11-14 2010-05-20 Lacer, S.A. New stereospecific method for the preparation of dioxa-bicyclooctane compounds
EP2199294A1 (en) * 2008-12-19 2010-06-23 Lacer, S.A. New stereospecific method for the preparation of dioxa bicyclooctane nitrate compounds
ES2587191T3 (es) * 2009-12-23 2016-10-21 Arca Biopharma, Inc. Métodos y composiciones para enfermedades y afecciones cardiovasculares
FR2977252B1 (fr) * 2011-06-30 2013-08-02 Seppic Sa Nouveaux esters de derives n-acyles d'acides amines et d'isosorbide, procede pour leur preparation, et utilisation en cosmetique et comme medicament.
KR101907050B1 (ko) 2011-12-16 2018-10-11 쓰리엠 이노베이티브 프로퍼티즈 컴파니 머캅토-함유 비스안하이드로헥시톨 유도체 및 이의 용도
RU2015139514A (ru) * 2013-03-05 2017-04-07 Арчер Дэниелс Мидлэнд Компани Монотрифлаты изогексида и способ их синтеза
CN116173012A (zh) * 2022-12-05 2023-05-30 温州医科大学 白当归脑在制备缺血性脑卒中神经保护用药物中的应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU465217B2 (en) * 1971-04-29 1975-09-18 American Home Products Corporation Mononitrte esters of 1,4:3, 6-dianhydro-d-glucitol
US3886186A (en) 1971-04-29 1975-05-27 American Home Prod Mononitrate esters of 1,4:3,6-dianhydro-d-glucitol
DE3102947A1 (de) 1981-01-29 1982-09-02 Heinrich Mack Nachf., 7918 Illertissen Verfahren zur herstellung von isosorbid-5-nitrat
IT1204571B (it) * 1987-05-08 1989-03-10 Chiesi Farma Spa Esteri di 1,4:3,6-dianidrosorbitolo-2-mononitrato e 5-mononitrato,loro procedimento di preparazione e loro composizioni farmaceutiche
US4891373A (en) * 1988-11-23 1990-01-02 Pfizer Inc. Aminopropanol derivatives of 1,4:3,6-dianhydrohexitol nitrates, processes for their preparation and their use as medicaments
FR2680173A1 (fr) * 1991-08-07 1993-02-12 Hoechst Lab Nitrates organiques, leurs procedes de preparation et leur utilisation dans le traitement de maladies cardiovasculaires .
WO1994003421A2 (en) * 1992-07-30 1994-02-17 Cal International Limited Esters and combinations of an organic nitrate and a salicylate
DE4410997A1 (de) * 1994-03-30 1995-10-26 Isis Pharma Gmbh Pharmazeutische Zubereitungen und Arzneistoffe zur Prävention und Behandlung endothelialer Dysfunktionen
IL120531A (en) * 1997-03-26 2006-12-31 Yissum Res Dev Co Nitric oxide donors and pharmaceutical compositions containing them
ES2142773B1 (es) * 1998-10-07 2001-01-01 Lacer Sa Derivados de mononitrato de isosorbida y su empleo como agentes vasodilatadores con tolerancia desminuida.
US20020013483A1 (en) * 2000-07-13 2002-01-31 Consortium Fur Elektrochemische Industrie Gmbh Process for the preparation of dianhydrohexitol bisacylates
EP1337283A4 (en) * 2000-10-27 2005-05-18 Nitromed Inc METHOD FOR THE TREATMENT OF VASCULAR DISORDERS MARKED BY STICK OXIDE DEFICIENCY
UA63467A (en) 2003-04-22 2004-01-15 Pharmaceutical composition of organic nitrates, dosage form based on pharmaceutical composition of organic nitrates and method of manufacture
ES2258365B1 (es) * 2003-10-03 2007-12-01 Lacer, S.A. Derivados de disulfuro, sulfuro, sulfoxido y sulfona de azucares ciclicos y sus usos.

Also Published As

Publication number Publication date
ES2322468T3 (es) 2009-06-22
DE112004001860T5 (de) 2006-07-27
MXPA06003610A (es) 2006-06-05
WO2005037842A1 (en) 2005-04-28
US7777058B2 (en) 2010-08-17
AR045962A1 (es) 2005-11-16
AU2004281916A1 (en) 2005-04-28
JP2011012081A (ja) 2011-01-20
PL1668017T3 (pl) 2009-07-31
NZ546043A (en) 2009-02-28
BRPI0415020A (pt) 2006-11-07
PE20050436A1 (es) 2005-06-23
AP1976A (en) 2009-03-16
KR20060066743A (ko) 2006-06-16
GB2421241B (en) 2008-04-16
UY28547A1 (es) 2005-04-29
EP1668017B1 (en) 2009-02-25
CN1863805A (zh) 2006-11-15
ATE423781T1 (de) 2009-03-15
US7521571B2 (en) 2009-04-21
SI1668017T1 (sl) 2009-08-31
CN1863805B (zh) 2010-06-16
US20090169560A1 (en) 2009-07-02
IL174371A0 (en) 2006-08-01
EA200600694A1 (ru) 2006-10-27
EP1668017A1 (en) 2006-06-14
HK1092807A1 (en) 2007-02-16
GB2421241A (en) 2006-06-21
AP2006003605A0 (en) 2006-04-30
EA008942B1 (ru) 2007-10-26
DE602004019666D1 (de) 2009-04-09
US8541607B2 (en) 2013-09-24
JP4809769B2 (ja) 2011-11-09
ECSP066542A (es) 2006-10-17
CA2540500A1 (en) 2005-04-28
NO20061872L (no) 2006-06-30
GB0605574D0 (en) 2006-04-26
ES2258365B1 (es) 2007-12-01
ZA200603475B (en) 2007-09-26
HRP20090152T3 (en) 2009-05-31
US20100196387A1 (en) 2010-08-05
KR101141683B1 (ko) 2012-05-07
ES2258365A1 (es) 2006-08-16
JP2007507451A (ja) 2007-03-29
IS8436A (is) 2006-05-03
GEP20084490B (en) 2008-09-25
GT200400200A (es) 2005-05-23
AU2004281916B2 (en) 2010-10-21
RS20060241A (sr) 2008-06-05
PT1668017E (pt) 2009-03-09
CA2540500C (en) 2012-08-28
PA8614201A1 (es) 2005-05-24
US20060235052A1 (en) 2006-10-19

Similar Documents

Publication Publication Date Title
DK1668017T3 (da) Disulfid-, sulfid-, sulfoxid- og sulfonderivater af cykliske sukkerarter og anvendelser deraf
DK2057153T3 (da) (3-aryl-piperazin-1-yl)-derivater af 6,7 dialkoxyquinazolin, 6,7- dialkoxyphtalazin og 6,7-dialkoxyisoquinolin
ATE556593T1 (de) Herbizide enthaltend substituierte thien-3-yl- sulfonylamino(thio)carbonyltriazolin(thi)one und flurtamone
DE60328925D1 (de) Jittergenerator
EP1828223A4 (en) Novel betulin derivatives, their preparation and their use
EP2091527A4 (en) SULFIDE, SULFOXIDE AND SULFON CHALCON ANALOGUE, DERIVATIVES THEREOF AND THERAPEUTIC APPLICATIONS THEREOF
DE60311031D1 (de) Öffnungsscharnier
ATE407172T1 (de) Schwefelpellet mit h2s-unterdrückungsmittel
DK1651644T3 (da) Substituerede derivater af thiazol-benzoisothiazoldioxid, fremgangsmåde deraf og deres anvendelse
NO20053564D0 (no) Bis(3)-alkoksyalkan-2-ol)sulfider, sulfoner og sulfoksider: nye overflateaktive midler.
ATE354566T1 (de) Aromatische sulfone und deren medizinische verwendung
EP1766314A4 (en) RECOVERY OF SULFUR HEXAFLUORIDE GAS
EP1650874A4 (en) Viterbi decoder
NO20054135D0 (no) Kipolinon/benzoksazin derivater og anvendelser derav
ITMI20041095A1 (it) Cerniera
DK1546357T3 (da) Immunogene polypeptider af mycoplasma pneumoniae
DK1896401T3 (da) Syntese af umættede sulfider, sulfoner, sulfoxider og sulfonamider
DE60315984D1 (de) Substituierte benzisoxazolsulfonamide mit breitbändiger hiv-protease hemmender wirkung
DK1282599T3 (da) Disulfidderivater, der er egnede til behandling af allergiske sygdomme
ITMI20020597A0 (it) Derivati del probucolo
PL1660633T3 (pl) Zamknięte komórki macierzyste i ich zastosowania
ATE417507T1 (de) Substituierte thien-3-yl- sulfonylamino(thio)carbonyl-triazolin(thi)one
EP1953182A4 (en) POLYMERIZABLE COMPOSITION AND POLYTHIOCARBONATE POLYTHIOETHER
DE60231170D1 (de) Optische teile und schwefelhaltiger polythioester
ATA9752003A (de) Flügel- und/oder stockrahmen